Preclinical development of epiready, a novel therapeutic to treat nonhealing diabetic foot ulcers

Ended Project Grant Awarded Last action

Award ID
W81XWH1610331
Recipient
Awarding agency
Obligated
$1,698,207

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Originally
Place of performance
Madison, WI 53719, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment Prerclinical development of epiready, a novel therapeutic to treat nonhealing diabetic foot uclers DE-obligate expiring funds -$659,453
Amendment Preclinical development of epiready, a novel therpeutic to treat nonhealing diabetic foot uclers extend the period of performance $0
Amendment $0
Amendment $0
Amendment $0
Amendment $0
Original award $2,357,660

Quick answers

Who received award W81XWH1610331?

W81XWH1610331 was awarded to Stratatech Corporation by Medical Command (Department of the Army) on July 1, 2016.

How much is award W81XWH1610331 worth?

$1,698,207 has been obligated on W81XWH1610331.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award